Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies

NCT ID: NCT06444503

Last Updated: 2024-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-16

Study Completion Date

2034-09-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this project is to set up a biological and clinical collection of patients with progressive bone, calcium and growth plate pathologies.

This collection will provide a better understanding of the mechanisms involved in growth plate and bone damage in these diseases and identify factors predictive of progression and new therapeutic targets.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients suffering from growth plate or bone pathology

As part of their pathology, patients benefit from clinical monitoring and regular blood and urine tests.

Biological samples

Intervention Type OTHER

Blood and urine will be taken in larger quantity

Biological

Intervention Type OTHER

Surgical residues may be preserved in the event of surgery carried out as part of the treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biological samples

Blood and urine will be taken in larger quantity

Intervention Type OTHER

Biological

Surgical residues may be preserved in the event of surgery carried out as part of the treatment.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children (from birth) with growth plate or bone pathology
* Patients affiliated to or benefiting from a social security scheme
* Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies :
* mastery of the French language
* Not being subject to a restriction of rights by the judicial authorities
* Patients or legal representatives having given their consent to participate in the study (expression of non-opposition).

Exclusion Criteria

* Patients under legal protection (guardianship, curatorship or safeguard of justice)
* Pregnant or breast-feeding women
Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas EDOUARD, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Toulouse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Toulouse Hospital

Toulouse, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thomas EDOUARD, MD

Role: CONTACT

0534558555 ext. +33

Sanaa EDDIRY

Role: CONTACT

0561776110 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thomas EDOUARD, MD

Role: primary

0534558555 ext. +33

Thomas EDOUARD, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC31/24/0214

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The BoDI (Bone Density Investigation) Study
NCT06117124 NOT_YET_RECRUITING NA